Goldman Sachs’s Accendra Health ACH Stock Holding History

Goldman Sachs’s Portfolio ACH Stock Details ACH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-67,700	Closed	-$2.94M	–	6816
2021 Q4	$2.94M	Hold	67,700	–	–	﹤0.01%	3907
2021 Q3	$2.12M	Hold	67,700	–	–	﹤0.01%	4152
2021 Q2	$2.87M	Hold	67,700	–	–	﹤0.01%	3869
2021 Q1	$2.54M	Buy	67,700 +17,700	+35%	+$553K	﹤0.01%	3751
2020 Q4	$1.35M	Buy	+50,000	New	+$1.29M	﹤0.01%	4004

Other funds holding ACH

CCM

Coliseum Capital Management Rowayton, Connecticut $1.16B AUM 23.26% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

ICM

Invenomic Capital Management Boston, Massachusetts $1.67B AUM 1.43% 1-Year Est. Return

Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

PCMI

Paradigm Capital Management Inc Albany, New York $3.67B AUM 121.12% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Goldman Sachs's ACH Position: Q2 2026 in Review

Goldman Sachs reduced its Accendra Health (ACH) stake by 9.2% in Q2 2026, selling an estimated $269K and leaving 854,730 shares worth $2.92M. The position accounts for ﹤0.01% of the portfolio, ranked #4364.

Goldman Sachs first reported a position in ACH in Q2 2013 and has held it in 53 quarters since. The position peaked at $62M in Q4 2021. 139 funds tracked by Wall St. Rank hold ACH as of Q2 2026.

Goldman Sachs held 854,730 shares of Accendra Health worth $2.92M as of Q2 2026.
Goldman Sachs sold 86,443 Accendra Health shares in Q2 2026, an estimated $269K.
Accendra Health made up ﹤0.01% of Goldman Sachs's portfolio in Q2 2026, its #4364 holding.
Goldman Sachs first reported a position in Accendra Health in Q2 2013 and has held it in 53 quarters since.
Goldman Sachs's Accendra Health position peaked at $62M in Q4 2021.
139 funds tracked by Wall St. Rank held Accendra Health as of Q2 2026.

Based on Goldman Sachs's 13F filing for Q2 2026, filed 14 Aug 2026.